The Majority of Autologous Cytolytic T-Lymphocyte Clones Derived from Peripheral Blood Lymphocytes of a Melanoma Patient Recognize an Antigenic Peptide Derived from Gene Pmel17/gp100-Reference-Cited by-同舟云学术

The Majority of Autologous Cytolytic T-Lymphocyte Clones Derived from Peripheral Blood Lymphocytes of a Melanoma Patient Recognize an Antigenic Peptide Derived from Gene Pmel17/gp100

Published:1996-07 Issue:1 Volume:107 Page:63-67
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Zarour Hassane,Smet Charles De,Lehmann Frédéric,Marchand Marie,Lethé Bernard,Romero Pedro,Boon Thierry,Renauld Jean-Christophe

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference25 articles.

1. Molecular characterization of the melanocyte lineage-specific antigen gp100;Adema;J Biol Chem,1994

2. Peptide synthesis. II. Procedures for solid phase synthesis using Na-fluorenylmethoxycarbamylamino-acid on polymide supports; synthesis of substance P and of acyl carrier protein 65-74 decapeptide;Atherton;J Chem Soc lond Perkin Trans,1981

3. Tumor antigens recognized by T lymphocytes;Boon;Annu Rev Immunol,1994

4. Conserved nucleotide sequences at the 5' end of T cell receptor variable genes facilitate polymerase chain reaction amplification;Broeren;Eur J Immunol,1991

5. Prognostic significance of hypopigmentation in malignant melanoma;Bystryn;Arch Dermatol,1987

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation cancer vaccines and emerging immunotherapy combinations;Trends in Cancer;2024-08

2. Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells;Life;2021-03-24

3. Endocrine Autoimmune Disease as a Fragility of Immune Surveillance against Hypersecreting Mutants;Immunity;2020-05

4. Endocrine autoimmune disease as a fragility of immune-surveillance against hypersecreting mutants;2019-11-17

5. Intracellular targets as source for cleaner targets for the treatment of solid tumors;Biochemical Pharmacology;2019-10